Andrew Hack

Dr. Andrew Hack has served as Managing Director at Bain Capital Life Sciences since 2019. Andrew currently serves on our Board of Directors and is a member of our Compensation Committee and chairman of our Audit Committee.

Dr. Hack previously served for as Chief Financial Officer of Editas Medicine (Nasdaq: EDIT) and as a healthcare portfolio manager at Millennium Management. Prior to that, he was a securities analyst at a number of healthcare-focused hedge funds and investment banks.

Dr. Hack received an MD and a PhD in molecular genetics and cell biology from the University of Chicago.